Previous 10 | Next 10 |
VolitionRx Limited Appoints Two New Directors PR Newswire AUSTIN, Texas , March 29, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help...
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and in...
VolitionRx Limited (VNRX) Q4 2020 Results Conference Call March 23, 2021 8:00 AM ET Company Participants Scott Powell - Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Dr. Jake Micallef - Chief Scientific Officer Conference Ca...
The following slide deck was published by VolitionRx Limited in conjunction with their 2020 Q4 earnings call. For further details see: VolitionRx Limited 2020 Q4 - Results - Earnings Call Presentation
VolitionRX (VNRX): FY GAAP EPS of -$0.45 in-line.Revenue of $0.01M (-50.0% Y/Y) in-line.10KPress Release For further details see: VolitionRX EPS and revenue in-line
VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Tuesday, March 23 at 8:00 a.m. U.S. Eastern Time PR Newswire Launched first product, the Nu.Q® V...
AUSTIN, Texas, March 22, 2021 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today a...
Detroit, Michigan--(Newsfile Corp. - March 19, 2021) - VolitionRx Limited (NYSE: VNRX) will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021. We invite our shareholders and all interested parties to explore biotech small cap investment opportunit...
NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations an...
VolitionRx shares rise (VNRX) after showcasing data indicating that Nu.Q assay is an effective method for monitoring Swiss-based private company Santersus' highly selective plasmapheresis treatment targeting Neutrophil Extracellular Traps ("NETs") in sepsis.The company also added th...
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...